Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reappraisal of Second-line Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus

NCT05057481 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05057481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reappraisal of Second-line Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus
Lead sponsor
Assiut University
Phase
Phase 3
Overall status
Unknown status
Start date
September 15, 2021
Completion date
January 15, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hemolytic anemia, systemic lupus erythematosus